Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
In an era when seemingly every tech company is vying to win the AI race, power has become the name of the game.
The retailer will cut prices on up to 5,000 grocery items to keep pace with lower-cost rivals like Walmart.
A loophole lets the company create a back-door offering of a generic drug before the patents of Novo Nordisk and Eli Lilly expire.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Hundreds of aviation startups are funneling billions of dollars toward what they hope will be a new form of low-emission air travel.
The retail giant posted $161 billion in quarterly revenue, marking a 6% increase and beating its earlier sales target.
The company started operating some fully driverless robotaxi rides in September 2023, and said 45% of Q4 orders were fully driverless models.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Comcast announced it would soon launch a new bundle that would package together its streaming service Peacock with Netflix and Apple TV+.
Sony said Tuesday that Playstation 5 sales rose over the past fiscal year, but it lowered its sales guidance over the next year.
The-commerce app, which has spent a fortune marketing itself in America, is reportedly starting to hedge its reliance on the US market.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.